ADVANCED BIOTHERAPY, INC.
Telephone
(818) 883-6716
Facsimile (818) 883-3353
November 26, 2002
By Facsimile
Cheri Carper Bennett, Esq.
Division of Corporation Finance
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
| Re: | Advanced Biotherapy, Inc. Registration Statement on Form SB-2 File No. 333-98747 |
Dear Ms. Carper Bennett:
This letter serves as notice that Advanced Biotherapy, Inc. (Company) hereby withdraws its Registration Statement on Form SB-2, SEC File No. 333-98747. In furtherance of your conversation in September, 2002, with our counsel, Joel Weinstein, we hereby request that the Securities and Exchange Commission apply the Company’s filing fees to a subsequent registration statement, which the Company may file covering the common stock underlying its Convertible Subordinated Pay-In-Kind Notes due September 30, 2004, and June 1, 2006, respectively.
For your reference, the Company recently terminated its private placement with respect to its Convertible Subordinated Pay-In-Kind Notes Due June 1, 2006. Should you have any questions regarding this notice of withdrawal, please contact the undersigned or our counsel, Joel Weinstein, at (310) 286-1700.
| Sincerely, | ||
| ADVANCED BIOTHERAPY, INC. | ||
| By: | /s/ Edmond F. Buccellato | |
| Edmond F. Buccellato President and Chief Executive Officer |
||